secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001104659-24-009012
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immunome promotes Max Rosett to EVP, Operations and Interim CFO; grants option for 175k shares
--------------------------------------------------------------------------------

- Max Rosett promoted from SVP, Operations and Interim CFO to EVP, Operations and Interim CFO effective Jan 31, 2024.
- Annual base salary increased to $425,000.
- Granted option to purchase 175,000 shares at $16.57 per share (closing price on grant date).
- Option vests 25% on one-year anniversary, then 36 equal monthly installments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924009012/0001104659-24-009012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924009012/tm244837d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-009012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer